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Abstract A gene encoding the larval excretory-secretory
antigen TES-120 of the dog ascarid worm Toxocara
canis was cloned into the methylotrophic yeast Pichia
pastoris. Speciﬁcity of the recombinant TES-120 antigen
produced by the yeast was investigated. Forty-ﬁve hu-
man serum samples from patients infected with diﬀer-
entparasitic organisms, including 8 cases of toxocariasis,
were tested against the recombinant antigen in immu-
noblot assays. Results from the assays showed that the
recombinant TES-120 antigen reacted with sera from
toxocariasis patients only. This highly speciﬁc
recombinant TES-120 antigen can potentially be used
for the development of an inexpensive serodiagnostic
assay for human toxocariasis.
Human toxocariasis is caused by infection with the lar-
vae of the dog ascarid worm Toxocara canis. Puppies
infected with adult T. canis shed in their feces large
number of infectious eggs into the environment. Larvae
hatched from T. canis eggs that are accidentally ingested
by a patient penetrate the intestinal wall and are carried
by the circulatory system to various organs (Glickman
and Schantz 1981). While the larvae do not undergo any
further development in the patient, the larvae can cause
local immunological reactions. During their somatic
migration through the organs, the larvae shed huge
amounts of immunogenic glycoproteins known as
Toxocara excretory-secretory (TES) antigens. The
shedding of large quantities of TES antigens is believed
to be a strategy of the larvae to escape the immune at-
tack of the host (Gems and Maizels 1996).
Human infections with T. canis larvae are usually
asymptomatic. However, in cases of heavy infection,
clinical presentations may be seen. The two main clinical
presentations are visceral larva migrans (VLM) and
ocular larva migrans (OLM) (Shields 1984; Schantz
1989). Diagnosis by identiﬁcation of the larvae in tissues
is rarely done. Antibody detection is the more com-
monly used method of conﬁrmation of toxocariasis. The
most common serologic test is enzyme-linked immuno-
sorbent assay (ELISA), which uses larval-stage antigens
extracted from embryonated eggs or TES antigens re-
leased by larvae cultured in vitro (de Savigny et al. 1979;
Jaquier et al. 1991). Assays using such antigens, how-
ever, have disadvantages. Firstly, the assays may yield
false positive results because of cross-reactivity with
other parasitic nematodes. Secondly, in vitro culture of
T. canis larvae and harvesting of TES antigens are
laborious and time consuming. Hence, there have been
attempts to produce speciﬁc recombinant antigens for
use in toxocariasis seroassays (Yamasaki et al. 1998,
2000).
The TES-120 glycoproteins of T. canis larvae are a
group of closely related mucins, which form the major
components of larval surface coat and ES antigens. Four
of the genes encoding these glycoproteins, designated
Tc-muc-1 to Tc-muc-4, have been cloned and charac-
terized (Loukas et al. 2000). Among these genes,
Tc-muc-1 is abundantly expressed and its encoded
product is highly antigenic (Gems and Maizels 1996;
Tetteh et al. 1999). We postulate that that TES-120 en-
coded by Tc-muc-1 would be a suitable candidate as a
highly speciﬁc recombinant antigen for use in toxocari-
asis seroassays. Hence, in our study, we expressed the
TES-120 protein in the Pichia pastoris yeast expression
system, which is well known for its ability to produce
high levels of recombinant proteins. The suitability of
this recombinant TES-120 as antigen was evaluated in
immunoblot assays.
Molecular cloning and expression of the Tc-muc-1
gene were carried out using conventional molecular
biology approaches. Firstly, an in vitro culture of
T. canis stage 2 larvae (L2) was established using the
method described by Maizels et al. (1984). Total RNA
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was extracted from 200,000 larvae using TRI reagent
(Molecular Research Center, USA). Reverse transcrip-
tion of RNA into cDNA was primed using oligo(dT)24
primer, and carried out with Superscript II reverse
transcriptase (GibcoBRL, Life Technologies, USA).
PCR ampliﬁcation of the resulting cDNA was carried
out using a primer pair consisting of the sense primer 5¢-
CTAGGTGAATTCACCATGCACGTCCTTACC-3¢
and the antisense primer 5¢-TTCGGCTGTGAATT-
CACAGAAGCCGCACGT-3¢, which ﬂanked the open
reading frame of the mature TES-120 peptide. The pri-
mer sequences were based on the sequence published by
Gems and Maizels (1996). The PCR product of 545 base
pairs was ligated into intermediate plasmid vector
pCR2.1-TOPO (Invitrogen, USA), and transformed into
competent Escherichia coli TOP10 cells. The TES-120
fragment in the recombinant plasmid was excised with
restriction endonuclease EcoRI, and then spliced in-
frame’ into the EcoRI cloning site of plasmid expression
vector pPICZ A (Invitrogen, USA). Positive re-
combinant pPICZ A clones harboring the TES-120
fragment were veriﬁed via nucleotide sequencing (data
not shown). The recombinant plasmid was then linear-
ized with SacI, and transformed into competent
P. pastoris cells using chemicals and instructions
provided in the EasySelect Pichia expression kit (Invi-
trogen, USA).
Expression of TES-120 antigen in the recombinant
P. pastoris was induced with 0.5%methanol. Protein was
harvested at 12-h intervals from pelleted P. pastoris cells,
and analyzed in denaturing sodium dodecyl sulfate-
polyacrylamide (SDS-PAGE) gels (Laemmli 1970)
stained with Coomassie blue. Gel analysis showed
expression of recombinant TES-120 antigen, with an
estimated size of 75 kDa, 24–36 h after induction
(Fig. 1a). This time interval was used as a guide when
growth and expression were done in a larger volume of
culture. Recombinant TES-120 antigen extracted from
large-volume culturewas puriﬁed using theXpress System
(Invitrogen, USA). The puriﬁcation system involved the
use of denaturing agents, and a dialysis step was carried
out to remove these agents. SDS-PAGE analysis of the
dialyzed recombinant TES-120 antigen showed a major
single band of 75 kDa (Fig. 1b). The puriﬁed re-
combinant antigen was electroblotted to nitrocellulose
membrane strips and tested with serum samples of pa-
tients suﬀering helminthic and protozoal infections.
Of the serum samples, 8 were from patients who were
serologically conﬁrmed as having toxocariasis antibody;
22 samples were from individuals who were serologically
positive for parasitic infections such as cysticercosis
(5 samples), ﬁlariasis (5), malaria (2), amebiasis (5) and
toxoplasmosis (5). In addition, sera from individuals
with soil-transmitted helminthiasis (STH) were also
tested; 5 serum samples were from individuals with
Ascaris lumbricoides and Trichuris trichiura co-infection,
3 with T. trichiura infection, and 1 each from cases of A.
lumbricoides and hookworm infection. In these STH
cases, the individuals were conﬁrmed positive by ﬁnding
of helminth eggs in their feces. As control, 5 sera from
normal healthy individuals were included in the immu-
noblot assays. Results from the immunoblot assays
showed that the recombinant TES-120 antigen reacted
with all the toxocariasis patients’ sera but none with the
Fig. 1a, b SDS-PAGE analysis of recombinant TES-120 antigen
produced in Pichia pastoris. a Time course study of recombinant
expression. Methanol (0.5%) was added to a recombinant P.
pastoris culture every 24 h to maintain induction of gene
expression, and samples (pelleted cells) were collected every 12 h.
Lane 1 is the protein molecular weight standard. Lane 2 was loaded
with sample from time zero (before induction). Lanes 3–5 were
loaded with samples collected 12, 24 and 36 h after induction,
respectively. The 75-kDa recombinant TES-120 protein (arrow)
appeared 24–36 h after induction. b Total protein from recombi-
nant P. pastoris cells were loaded onto the Xpress System
puriﬁcation column. Eluted material from the column contained
mostly the 75-kDa recombinant TES-120 protein (lane 3). Lane 2 is
the eluate from a column loaded with total protein from a non-
recombinant P. pastoris cell (negative control). Lane 1 is the protein
molecular weight standard
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normal sera or sera from patients with non-Toxocara
parasitic infection (a sample blot is presented in Fig. 2).
The results thus indicate that the recombinant antigen
was speciﬁc for anti-Toxocara antibody. More crucially,
the recombinant TES-120 antigen did not cross-react
with antibodies from patients with other helminthic
infections.
Most of the commercial toxocariasis seroassay kits
use total TES antigens derived from larva culture in
vitro. These antigens are heterogeneous in their com-
position, and may increase the possibility of cross-
reaction with non-Toxocara helminth antibodies.
However, using a single or homogenous species of
Toxocara canis larval antigen, such as those produced
by recombinant DNA technology, should be more
reliable and speciﬁc. In our study, we chose the Pichia
expression system because it oﬀers several advantages
over any other expression systems. In addition to its
ability to produce high levels of recombinant proteins,
up to grams-per-liter culture (Clare et al. 1991), the
Pichia system has eukaryotic post-translational modi-
ﬁcation mechanisms which can glycosylate and fold
recombinant proteins into forms that are similar to
those of the native proteins (Cregg et al. 1993). The
recombinant proteins can be selectively secreted by the
P. pastoris into the growth medium, and this makes
harvesting and puriﬁcation of the proteins much easier.
Furthermore, this methylotrophic yeast is not a fas-
tidious organism, and is capable of utilizing methanol
as its sole carbon source. Thus, it can be grown in
simple and inexpensive growth medium. Finally,
growing large-culture P. pastoris to produce re-
combinant antigens would not be diﬃcult as that the
technology for large-scale culture or fermentation of
yeast is very established.
In conclusion, our ﬁndings in this study have laid the
foundation for our further endeavor in producing a
highly speciﬁc recombinant antigen that can be used for
development of an inexpensive seroassay kit for human
toxocariasis.
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